Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $116.20
-
Support level$112.03
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)58.6
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 63.3 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Up 7.4 percent, GILD is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$72.99 | $117.41 | 97.8% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$101.10 | $109.40 | $111.31 | $110.94 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.1%
-
In the next month13.4%
-
In the next year53.0%
Period | Value |
---|---|
Historical (5 year) | 23.4% |
Last month | 23.2% |
Current estimate | 22.4% |
Next month forecast | 23.7% |